UBS Group’s CeriBell Inc CBLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$472K Sell
24,282
-12,540
-34% -$238K ﹤0.01% 6268
2026
Q1
$675K Sell
36,822
-48,590
-57% -$976K ﹤0.01% 5842
2025
Q4
$1.87M Sell
85,412
-171,507
-67% -$2.66M ﹤0.01% 5040
2025
Q3
$2.95M Buy
256,919
+107,482
+72% +$1.45M ﹤0.01% 4580
2025
Q2
$2.8M Buy
149,437
+129,486
+649% +$2.2M ﹤0.01% 4457
2025
Q1
$383K Sell
19,951
-15,735
-44% -$350K ﹤0.01% 6070
2024
Q4
$924K Buy
+35,686
New +$972K ﹤0.01% 5366

Other funds holding CBLL

UBS Group's CBLL Position: Q2 2026 in Review

UBS Group reduced its CeriBell Inc (CBLL) stake by 34% in Q2 2026, selling an estimated $238K and leaving 24,282 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #6268.

UBS Group first reported a position in CBLL in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.95M in Q3 2025. 122 funds tracked by Wall St. Rank hold CBLL as of Q2 2026.

  • UBS Group held 24,282 shares of CeriBell Inc worth $472K as of Q2 2026.
  • UBS Group sold 12,540 CeriBell Inc shares in Q2 2026, an estimated $238K.
  • CeriBell Inc made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6268 holding.
  • UBS Group first reported a position in CeriBell Inc in Q4 2024 and has held it in 7 quarters since.
  • UBS Group's CeriBell Inc position peaked at $2.95M in Q3 2025.
  • 122 funds tracked by Wall St. Rank held CeriBell Inc as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.